XBIO: Xenetic Biosciences, Inc. Stock

by  •  • Comments Off on XBIO: Xenetic Biosciences, Inc. Stock

SIC 2834 – Pharmaceutical Preparations

Valuation
Market Cap ($M) 6.26
Enterprise Value ($M) -0.58
Book Value ($M) 7.04
Book Value / Share 4.56
Price / Book 0.89
NCAV ($M) 6.02
NCAV / Share 3.90
Price / NCAV 1.04

Profitability (mra)
Return on Invested Capital (ROIC) -0.58
Return on Assets (ROA) -0.38
Return on Equity (ROE) -0.42

Liquidity (mrq)
Quick Ratio 6.96
Current Ratio 6.96

Balance Sheet (mrq) ($M)
Current Assets 7.03
Assets 8.05
Liabilities 1.01
Debt n/a
Equity n/a

Income Statement (mra) ($M)
Revenue 0.00
Operating Income 0.00
Net Income 0.00
Earnings Per Share Basic And Diluted n/a

Cash Flow Statement (mra) ($M)
Cash From Operations 0.00
Cash from Investing 0.00
Cash from Financing 0.00

(click for more detail)

File Date Form Activist 13D/G Investors Ownership
(%)		 Change
(%)
03-18 13D/A CLS Therapeutics, LLC 14.00 8.59

Top 13F Investors Shares
(1000)		 Change
(%)		 Value
($1000)		 Change
(%)

(click for more detail)

Date Insider Trades Code Shares Value

(click for more detail)

File Date Form SEC Filings
2024-11-12 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, DC 20549 FORM 10-Q
2024-08-13 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, DC 20549 FORM 10-Q
2024-03-21 10-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, DC 20549 Form 10-K

(click for more detail)
Short Volume
Market Date Short Volume Total Volume Short Volume Ratio
2025-02-04 2,742 6,840 40.09
2025-02-03 30 3,442 0.87
2025-01-31 1,613 7,272 22.18
2025-01-30 1,125 3,288 34.22

(click for more detail)

Similar Companies
VXRT – Vaxart, Inc. VYNE – VYNE Therapeutics Inc.
WINT – Windtree Therapeutics, Inc. XCUR – Exicure, Inc.
XFOR – X4 Pharmaceuticals, Inc.


Financial data and stock pages provided by
Fintel.io